Business Development

Magen is actively seeking to in-license clinical stage (Phase 1-3) and near-IND small molecule compounds with potential utility in dermatology.  We will also evaluate earlier stage opportunities with an outstanding scientific basis. Compounds fitting these criteria will be reviewed in a timely and thorough manner.

Magen is committed to building strong partnerships through open communication, flexibility, and appropriate allocation of resources.  Once a partnership is established, we put forth the highest standards of drug development, while being ever cognizant that speed of development can dramatically affect value for our partner and ourselves alike.

To discuss a licensing or partnering opportunity, please contact us at: info@magenbiosciences.com or call us at: 781-314-2900.